Office of Biotechnology Activities, Office of Science Policy, Office of the Director; Notice of Meeting, 25255 [E9-12275]

Download as PDF Federal Register / Vol. 74, No. 100 / Wednesday, May 27, 2009 / Notices Place: Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, Bethesda, MD 20852. Contact Person: Tony L. Creazzo, PhD, Scientific Review Officer, Review Branch/ DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7180, Bethesda, MD 20892–7924, 301–435–0725, creazzot@mail.nih.gov. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel, NHLBI Pediatric Cardiac Genomics Consortium. Date: June 17, 2009. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, Bethesda, MD 20852. Contact Person: Tony L. Creazzo, PhD, Scientific Review Officer, Review Branch/ DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7180, Bethesda, MD 20892–7924, 301–435–0725, creazzot@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) Dated: May 19, 2009 Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–12242 Filed 5–26–09; 8:45 am] Date: May 27, 2009. Open: 1 p.m. to 2:30 p.m. Agenda: Presentations and discussions regarding revisions to the draft NSABB report on Enhancing Personnel Reliability among Individuals with Access to Select Agents and Toxins. Place: National Institutes of Health, Office of Biotechnology Activities, Suite 750, Bethesda, Maryland 20892. (Telephone Conference Call). Call-in Information: Toll-Free Number: 1– 800–988–9458. Participant Passcode: NSABB. Contact Person: Ronna Hill, NSABB Program Assistant, 6705 Rockledge Drive, Bethesda, Maryland 20892. (301) 496–9838. The teleconference meeting agenda, revised draft report and other information about the NSABB will be available at https://www.biosecurityboard.gov Please check this Web site for updates. The teleconference will include opportunity for public comment. In addition, any interested person may file written comments with the committee. All written comments must be received by May 26, 2009 and should be sent via e-mail to nsabb@od.nih.gov with ‘‘NSABB Public Comment’’ as the subject line or by regular mail to 6705 Rockledge Drive, Suite 750, Bethesda, MD 20892, Attention: Ronna Hill. The statement should include the name, address, telephone number and, when applicable, the business or professional affiliation of the interested person. This notice is being published less than 15 days prior to the meeting due to time restraints placed on Committee deliberations. Dated: May 18, 2009. Jennifer Spaeth, Office of Federal Advisory Committee Policy. [FR Doc. E9–12275 Filed 5–26–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4140–01–P National Institutes of Health erowe on PROD1PC63 with NOTICES Office of Biotechnology Activities, Office of Science Policy, Office of the Director; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a public teleconference of the National Science Advisory Board for Biosecurity (NSABB). Under authority 42 U.S.C. 217a, section 222 of the Public Health Service Act, as amended, the Department of Health and Human Services established NSABB to provide advice, guidance and leadership regarding Federal oversight of dual use research, defined as biological research with legitimate scientific purposes that could be misused to pose a biological threat to public health and/or national security. A publicly accessible teleconference line will be available for the meeting. Name of Committee: National Science Advisory Board for Biosecurity. VerDate Nov<24>2008 15:23 May 26, 2009 Jkt 217001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and552b(c)(6), Title 5 U.S.C., as amended. The grant applications and PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 25255 the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Initial Review Group; Diabetes, Endocrinology and Metabolic Diseases B Subcommittee. Date: June 13–14, 2009. Open: June 13, 2009, 5:30 p.m. to 6 p.m. Agenda: To review procedures and discuss policy. Place: Four Points Sheraton, 1201 K Street, NW., Washington, DC 20005. Closed: June 13, 2009, 6:00 p.m. to 9:30 p.m. Agenda: To review and evaluate grant applications. Place: Four Points Sheraton, 1201 K Street, NW., Washington, DC 20005. Closed: June 14, 2009, 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Four Points Sheraton, 1201 K Street, NW., Washington, DC 20005. Contact Person: John F. Connaughton, PhD, Chief, Chartered Committees Section, Review Branch, DEA, NIDDK, National Institutes of Health, Room 753, 6707 Democracy Boulevard, Bethesda, MD 20892–5452, (301) 594–7797, connaughtonj@extra.niddk.nih.gov. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Initial Review Group; Digestive Diseases and Nutrition C Subcommittee. Date: June 17–18, 2009. Open: June 17, 2009, 8 a.m. to 8:30 a.m. Agenda: To review procedures and discuss policy. Place: Georgetown Suites, 1000 29th Street NW., Washington, DC 20007. Closed: June 17, 2009, 8:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Georgetown Suites, 1000 29th Street NW., Washington, DC 20007. Closed: June 18, 2009, 8 a.m. to 2 p.m. Agenda: To review and evaluate grant applications. Place: Georgetown Suites, 1000 29th Street, NW., Washington, DC 20007. Contact Person: Dan E. Matsumoto, PhD, Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 749, 6707 Democracy Boulevard, Bethesda, MD 20892–5452, (301) 594–8894, matsumotod@extra.niddk.nih.gov. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Initial Review Group; Kidney, Urologic and Hematologic Diseases D Subcommittee. Date: June 24–25, 2009. Open: June 24, 2009, 8 a.m. to 8:30 a.m. Agenda: To review procedures and discuss policy. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. E:\FR\FM\27MYN1.SGM 27MYN1

Agencies

[Federal Register Volume 74, Number 100 (Wednesday, May 27, 2009)]
[Notices]
[Page 25255]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-12275]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of Biotechnology Activities, Office of Science Policy, 
Office of the Director; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a public 
teleconference of the National Science Advisory Board for Biosecurity 
(NSABB).
    Under authority 42 U.S.C. 217a, section 222 of the Public Health 
Service Act, as amended, the Department of Health and Human Services 
established NSABB to provide advice, guidance and leadership regarding 
Federal oversight of dual use research, defined as biological research 
with legitimate scientific purposes that could be misused to pose a 
biological threat to public health and/or national security.
    A publicly accessible teleconference line will be available for the 
meeting.

    Name of Committee: National Science Advisory Board for 
Biosecurity.
    Date: May 27, 2009.
    Open: 1 p.m. to 2:30 p.m.
    Agenda: Presentations and discussions regarding revisions to the 
draft NSABB report on Enhancing Personnel Reliability among 
Individuals with Access to Select Agents and Toxins.
    Place: National Institutes of Health, Office of Biotechnology 
Activities, Suite 750, Bethesda, Maryland 20892. (Telephone 
Conference Call).
    Call-in Information: Toll-Free Number: 1-800-988-9458. 
Participant Passcode: NSABB.
    Contact Person: Ronna Hill, NSABB Program Assistant, 6705 
Rockledge Drive, Bethesda, Maryland 20892. (301) 496-9838.
    The teleconference meeting agenda, revised draft report and 
other information about the NSABB will be available at https://www.biosecurityboard.gov Please check this Web site for updates.
    The teleconference will include opportunity for public comment. 
In addition, any interested person may file written comments with 
the committee. All written comments must be received by May 26, 2009 
and should be sent via e-mail to nsabb@od.nih.gov with ``NSABB 
Public Comment'' as the subject line or by regular mail to 6705 
Rockledge Drive, Suite 750, Bethesda, MD 20892, Attention: Ronna 
Hill. The statement should include the name, address, telephone 
number and, when applicable, the business or professional 
affiliation of the interested person.

This notice is being published less than 15 days prior to the 
meeting due to time restraints placed on Committee deliberations.

    Dated: May 18, 2009.
Jennifer Spaeth,
Office of Federal Advisory Committee Policy.
[FR Doc. E9-12275 Filed 5-26-09; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.